Cargando…
High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
Solute Carrier Family 1, member 5 (SLC1A5), also named as ASCT2, a major glutamine transporter, is highly expressed in various malignancies and plays a critical role in the transformation, growth and survival of cancer cells. The aim of this study was to assess the clinical significance of SLC1A5 in...
Autores principales: | Liu, Yidong, Yang, Liu, An, Huimin, Chang, Yuan, Zhang, Weijuan, Zhu, Yu, Xu, Le, Xu, Jiejie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657035/ https://www.ncbi.nlm.nih.gov/pubmed/26599282 http://dx.doi.org/10.1038/srep16954 |
Ejemplares similares
-
High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015) -
Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016) -
Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma
por: Liu, Weisi, et al.
Publicado: (2016) -
Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma
por: Yang, Liu, et al.
Publicado: (2015) -
P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2015)